Outcomes of 1st Remission Induction Chemotherapy in Acute Myeloid Leukemia Cytogenetic Risk Groups

BACKGROUND: Diagnostic karyotyping analysis is routinely used in acute myeloid leukemia (AML) clinics. Categorization of patients into risk stratified groups (favorable, intermediate and adverse) according to cytogenetic findings can serve as a valuable independent prognostic factor. METHOD AND MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Zehra, Samreen, Najam, Rahela, Farzana, Tasneem, Shamsi, Tahir Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454667/
https://www.ncbi.nlm.nih.gov/pubmed/28125870
http://dx.doi.org/10.22034/APJCP.2016.17.12.5251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454667/
https://www.ncbi.nlm.nih.gov/pubmed/28125870
http://dx.doi.org/10.22034/APJCP.2016.17.12.5251

Ejemplares similares